128 related articles for article (PubMed ID: 7575994)
1. Pancreatic lymph nodes are early targets of T cells during adoptive transfer of diabetes in NOD mice.
Fabien N; Bergerot I; Maguer-Satta V; Orgiazzi J; Thivolet C
J Autoimmun; 1995 Jun; 8(3):323-34. PubMed ID: 7575994
[TBL] [Abstract][Full Text] [Related]
2. Diabetogenic T cells are primed both in pancreatic and gut-associated lymph nodes in NOD mice.
Jaakkola I; Jalkanen S; Hänninen A
Eur J Immunol; 2003 Dec; 33(12):3255-64. PubMed ID: 14635033
[TBL] [Abstract][Full Text] [Related]
3. Pancreas-infiltrating Th1 cells and diabetes develop in IL-12-deficient nonobese diabetic mice.
Trembleau S; Penna G; Gregori S; Chapman HD; Serreze DV; Magram J; Adorini L
J Immunol; 1999 Sep; 163(5):2960-8. PubMed ID: 10453045
[TBL] [Abstract][Full Text] [Related]
4. Upregulating CD4+CD25+FOXP3+ regulatory T cells in pancreatic lymph nodes in diabetic NOD mice by adjuvant immunotherapy.
Tian B; Hao J; Zhang Y; Tian L; Yi H; O'Brien TD; Sutherland DE; Hering BJ; Guo Z
Transplantation; 2009 Jan; 87(2):198-206. PubMed ID: 19155973
[TBL] [Abstract][Full Text] [Related]
5. Mucosal addressin is required for the development of diabetes in nonobese diabetic mice.
Hänninen A; Jaakkola I; Jalkanen S
J Immunol; 1998 Jun; 160(12):6018-25. PubMed ID: 9637517
[TBL] [Abstract][Full Text] [Related]
6. Effects of insulin like growth factor-1 and insulin on effector T cells generating autoimmune diabetes.
Bergerot I; Fabien N; Thivolet C
Diabetes Metab; 1996 Jul; 22(4):235-9. PubMed ID: 8767168
[TBL] [Abstract][Full Text] [Related]
7. Interleukin 2 receptor targeted fusion toxin (DAB486-IL-2) treatment blocks diabetogenic autoimmunity in non-obese diabetic mice.
Pacheco-Silva A; Bastos MG; Muggia RA; Pankewycz O; Nichols J; Murphy JR; Strom TB; Rubin-Kelley VE
Eur J Immunol; 1992 Mar; 22(3):697-702. PubMed ID: 1547815
[TBL] [Abstract][Full Text] [Related]
8. Lymphoid hyperplasia, CD45RBhigh to CD45RBlow T-cell imbalance, and suppression of Type I diabetes mellitus result from TNF blockade in NOD-->NOD-scid adoptive T cell transfer.
Brown GR; Silva MD; Thompson PA; Beutler B
Diabetologia; 1998 Dec; 41(12):1502-10. PubMed ID: 9867218
[TBL] [Abstract][Full Text] [Related]
9. Characteristics of rat CD4(+)CD25(+) T cells and their ability to prevent not only diabetes but also insulitis in an adoptive transfer model in BB rats.
Holm TL; Lundsgaard D; Markholst H
Scand J Immunol; 2006 Jul; 64(1):17-29. PubMed ID: 16784487
[TBL] [Abstract][Full Text] [Related]
10. Pancreatic infiltration but not diabetes occurs in the relative absence of MHC class II-restricted CD4 T cells: studies using NOD/CIITA-deficient mice.
Mora C; Wong FS; Chang CH; Flavell RA
J Immunol; 1999 Apr; 162(8):4576-88. PubMed ID: 10201997
[TBL] [Abstract][Full Text] [Related]
11. TCR repertoire dynamics in the pancreatic lymph nodes of non-obese diabetic (NOD) mice at the time of disease initiation.
Petrovic Berglund J; Mariotti-Ferrandiz E; Rosmaraki E; Hall H; Cazenave PA; Six A; Höglund P
Mol Immunol; 2008 Jun; 45(11):3059-64. PubMed ID: 18471883
[TBL] [Abstract][Full Text] [Related]
12. Pancreatic IL-4 expression results in islet-reactive Th2 cells that inhibit diabetogenic lymphocytes in the nonobese diabetic mouse.
Gallichan WS; Balasa B; Davies JD; Sarvetnick N
J Immunol; 1999 Aug; 163(3):1696-703. PubMed ID: 10415077
[TBL] [Abstract][Full Text] [Related]
13. High density insulin receptor-positive T lymphocytes from nonobese diabetic mice transfer insulitis and diabetes.
McInerney MF; Flynn JC; Goldblatt PJ; Najjar SM; Sherwin RS; Janeway CA
J Immunol; 1996 Oct; 157(8):3716-26. PubMed ID: 8871675
[TBL] [Abstract][Full Text] [Related]
14. NOD fetal thymus organ culture: an in vitro model for the development of T cells involved in IDDM.
Wilson SS; DeLuca D
J Autoimmun; 1997 Oct; 10(5):461-72. PubMed ID: 9376074
[TBL] [Abstract][Full Text] [Related]
15. Complete Freund's adjuvant-induced T cells prevent the development and adoptive transfer of diabetes in nonobese diabetic mice.
Qin HY; Sadelain MW; Hitchon C; Lauzon J; Singh B
J Immunol; 1993 Mar; 150(5):2072-80. PubMed ID: 8436836
[TBL] [Abstract][Full Text] [Related]
16. Bone marrow is a preferential homing site for autoreactive T-cells in type 1 diabetes.
Li R; Perez N; Karumuthil-Melethil S; Vasu C
Diabetes; 2007 Sep; 56(9):2251-9. PubMed ID: 17596402
[TBL] [Abstract][Full Text] [Related]
17. Marginal-zone B-cells of nonobese diabetic mice expand with diabetes onset, invade the pancreatic lymph nodes, and present autoantigen to diabetogenic T-cells.
Mariño E; Batten M; Groom J; Walters S; Liuwantara D; Mackay F; Grey ST
Diabetes; 2008 Feb; 57(2):395-404. PubMed ID: 18025414
[TBL] [Abstract][Full Text] [Related]
18. Paradoxical lessening of autoimmune processes in non-obese diabetic mice after infection with the diabetogenic variant of encephalomyocarditis virus.
Hermitte L; Vialettes B; Naquet P; Atlan C; Payan MJ; Vague P
Eur J Immunol; 1990 Jun; 20(6):1297-303. PubMed ID: 2164479
[TBL] [Abstract][Full Text] [Related]
19. Increased diabetes development and decreased function of CD4+CD25+ Treg in the absence of a functional DAP12 adaptor protein.
Hall HT; Sjölin H; Brauner H; Tomasello E; Dalod M; Vivier E; Höglund P
Eur J Immunol; 2008 Nov; 38(11):3191-9. PubMed ID: 18925576
[TBL] [Abstract][Full Text] [Related]
20. Analysis of leukocytes recruited to the pancreas by diabetogenic T cell clones.
Peterson JD; Berg R; Piganelli JD; Poulin M; Haskins K
Cell Immunol; 1998 Nov; 189(2):92-8. PubMed ID: 9790722
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
